Natural killer cell activation and inhibition by receptors for MHC class I - PubMed (original) (raw)
Review
Natural killer cell activation and inhibition by receptors for MHC class I
M López-Botet et al. Curr Opin Immunol. 1999 Jun.
Abstract
Several recent advances have been made in our understanding of the mechanisms which human natural killer cells recognize MHC class I molecules. Three are of special relevance: the identification of a novel molecule (DAP12) with a key role in the activation pathways; the observation that certain immunoglobulin-like receptors for HLA class I molecules are also utilized by other leucocyte lineages; and the definition of MHC class Ib proteins (i.e. HLA-E and Qa-1b) as specific ligands for the phylogenetically conserved CD94-NKG2 lectin-like receptors.
Similar articles
- HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. Braud VM, et al. Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869. Nature. 1998. PMID: 9486650 - Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
Valés-Gómez M, Reyburn HT, Erskine RA, López-Botet M, Strominger JL. Valés-Gómez M, et al. EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250. EMBO J. 1999. PMID: 10428963 Free PMC article. - HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM. King A, et al. Eur J Immunol. 2000 Jun;30(6):1623-31. doi: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M. Eur J Immunol. 2000. PMID: 10898498 - Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
O'Callaghan CA. O'Callaghan CA. Microbes Infect. 2000 Apr;2(4):371-80. doi: 10.1016/s1286-4579(00)00330-0. Microbes Infect. 2000. PMID: 10817639 Review. - Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.
Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Peña J, Solana R, Coligan JE. Borrego F, et al. Mol Immunol. 2002 Feb;38(9):637-60. doi: 10.1016/s0161-5890(01)00107-9. Mol Immunol. 2002. PMID: 11858820 Review.
Cited by
- Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.
Rodriguez GM, Yakubovich E, Vanderhyden BC. Rodriguez GM, et al. Cancers (Basel). 2023 Dec 2;15(23):5694. doi: 10.3390/cancers15235694. Cancers (Basel). 2023. PMID: 38067396 Free PMC article. Review. - A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients.
Ko Y, Wee YM, Shin S, Kim MJ, Choi MY, Kim DH, Lim SJ, Jung JH, Kwon H, Kim YH, Han DJ. Ko Y, et al. PLoS One. 2023 Mar 1;18(3):e0280924. doi: 10.1371/journal.pone.0280924. eCollection 2023. PLoS One. 2023. PMID: 36857393 Free PMC article. Clinical Trial. - Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W, Lansiaux P, Lambert NC, Picard C, Clave E, Cras A, Marjanovic Z, Farge D, Tamouza R. Boukouaci W, et al. Int J Mol Sci. 2022 Jun 29;23(13):7223. doi: 10.3390/ijms23137223. Int J Mol Sci. 2022. PMID: 35806227 Free PMC article. - HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder.
Boukouaci W, Lajnef M, Richard JR, Wu CL, Bouassida J, Rafik I, Foiselle M, Straczek C, Mezouad E, Naamoune S, Salah S, Bencharif MA, Ben Chaaben A, Barau C, Le Corvoisier P, Leboyer M, Tamouza R. Boukouaci W, et al. Sci Rep. 2021 Oct 12;11(1):20260. doi: 10.1038/s41598-021-99732-9. Sci Rep. 2021. PMID: 34642395 Free PMC article. - Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.
Lu T, Ma R, Li Z, Mansour AG, Teng KY, Chen L, Zhang J, Barr T, Caligiuri MA, Yu J. Lu T, et al. Cancer Immunol Res. 2021 Oct;9(10):1229-1241. doi: 10.1158/2326-6066.CIR-20-1014. Epub 2021 Jul 29. Cancer Immunol Res. 2021. PMID: 34326137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials